Central Florida Retina is currently enrolling patients who are interested in participating in one of the following studies.
For patients who have been diagnosed with Age Related Macular Degeneration
Testing a new investigational drug in the form of an eye drop for patients who have been diagnosed with Wet or Dry AMD
Phase 2b study for patients with Dry AMD specific to Geographic Atrophy.
Phase 3 study for patients with Wet AMD using mono therapy.
For patients who have been diagnosed with Alzheimer Disease
Phase 2/3 study to examine and test for retinal effects and visual changes while being administered disease specific study drug for dementia.
Study designed to observe and identify the risk factors that contribute to genetic Age Related Macular Degeneration.
Study designed to assist in Blood/DNA collection for the National Ophthalmic Disease Genotyping and Phenotyping Network.
Attention Patients and Doctors
If you are interested in obtaining more information or would like to enroll in one of these studies, please contact CFR’s Clinical Research Department at email@example.com.